INTEGRILIN

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug INTEGRILIN contains one active pharmaceutical ingredient (API):

1 Eptifibatide UNII NA8320J834 - EPTIFIBATIDE

Eptifibatide is an inhibitor of platelet aggregation and belongs to the class of RGD (arginine-glycine-aspartate)-mimetics. Eptifibatide reversibly inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor and other adhesive ligands to the glycoprotein (GP) IIb/IIIa receptors. Read about Eptifibatide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INTEGRILIN Solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC16	Eptifibatide	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8683B, 8684C
Country: CA	Health Products and Food Branch	Identifier(s): 02240351, 02240352
Country: EE	Ravimiamet	Identifier(s): 1183845, 1183856
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 99109001, 99109002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 136093, 136101
Country: FR	Base de données publique des médicaments	Identifier(s): 60124020, 66506404
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 48489, 48500
Country: HK	Department of Health Drug Office	Identifier(s): 46243, 46244
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3734, 3735
Country: IT	Agenzia del Farmaco	Identifier(s): 034489017, 034489029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028451, 1028452, 1050913
Country: NL	Z-Index G-Standaard	Identifier(s): 14298406, 14298414
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 53708, 53716
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7864, 7865
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100100483, 100100490
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65094001, W65095001
Country: SG	Health Sciences Authority	Identifier(s): 11222P, 11223P
Country: US	FDA, National Drug Code	Identifier(s): 0085-1136, 0085-1177
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/8.2/0540